156 related articles for article (PubMed ID: 8849256)
1. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains.
Azoulay-Dupuis E; Moine P; Bedos JP; Rieux V; Vallee E
Antimicrob Agents Chemother; 1996 Apr; 40(4):941-6. PubMed ID: 8849256
[TBL] [Abstract][Full Text] [Related]
2. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
[TBL] [Abstract][Full Text] [Related]
3. Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics.
Abgueguen P; Azoulay-Dupuis E; Noel V; Moine P; Rieux V; Fantin B; Bedos JP
Antimicrob Agents Chemother; 2007 Jan; 51(1):208-14. PubMed ID: 17060515
[TBL] [Abstract][Full Text] [Related]
4. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
[TBL] [Abstract][Full Text] [Related]
5. Correlation between in vitro and in vivo activity of amoxicillin against Streptococcus pneumoniae in a murine pneumonia model.
Moine P; Mazoit JX; Bédos JP; Vallée E; Azoulay-Dupuis E
J Pharmacol Exp Ther; 1997 Jan; 280(1):310-5. PubMed ID: 8996211
[TBL] [Abstract][Full Text] [Related]
6. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
[TBL] [Abstract][Full Text] [Related]
7. In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Chavanet P; Peyrard N; Pechinot A; Buisson M; Duong M; Neuwirth C; Kazmierczak A; Portier H
Antimicrob Agents Chemother; 1996 Sep; 40(9):2062-66. PubMed ID: 8878581
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
Lepak AJ; Andes DR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
[TBL] [Abstract][Full Text] [Related]
9. Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.
Lister PD; Pong A; Chartrand SA; Sanders CC
Antimicrob Agents Chemother; 1997 Sep; 41(9):1926-32. PubMed ID: 9303386
[TBL] [Abstract][Full Text] [Related]
10. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin.
Pérez-Trallero E; Alkorta M; Giménez MJ; Vicente D; Aguilar L
J Chemother; 2001 Apr; 13(2):118-25. PubMed ID: 11330357
[TBL] [Abstract][Full Text] [Related]
11. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
[TBL] [Abstract][Full Text] [Related]
12. In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.
Andes D; Craig WA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2375-9. PubMed ID: 9736566
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
Sevillano D; Aguilar L; Alou L; Giménez MJ; González N; Echeverría O; Torrico M; Valdes L; Coronel P; Prieto J
Chemotherapy; 2008; 54(2):84-90. PubMed ID: 18303256
[TBL] [Abstract][Full Text] [Related]
14. Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
File TM; Jacobs MR; Poole MD; Wynne B;
Int J Antimicrob Agents; 2002 Oct; 20(4):235-47. PubMed ID: 12385678
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.
Aguilar L; Rosendo J; Balcabao IP; Martín M; Giménez MJ; Frías J; Prieto J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1389-91. PubMed ID: 9174206
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Bédos JP; Rieux V; Bauchet J; Muffat-Joly M; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1998 Apr; 42(4):862-7. PubMed ID: 9559797
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.
Thorburn CE; Knott SJ; Edwards DI
Antimicrob Agents Chemother; 1998 Aug; 42(8):1973-9. PubMed ID: 9687392
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
[TBL] [Abstract][Full Text] [Related]
19. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
McCracken GH; Sakata Y
Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
